Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc. | Chief Financial Officer | $5.36M | Mar 1, 2024 | ||
VIR | Vir Biotechnology, Inc. | Cfo | $353K | Feb 23, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|